期刊文献+

铜绿假单胞菌3型O-特异性多糖-破伤风类毒素结合疫苗的制备及其免疫特性分析 被引量:3

Preparation and immune characteristics of Pseudomonas aeruginosa-IATS 3 O-specific polysaccharide-tetanus toxoid conjugate
原文传递
导出
摘要 目的研制铜绿假单胞菌3型O-特异性多糖(O-specific polysaccharide,O-SP)-破伤风类毒素(Tetanus toxoid,TT)结合疫苗,并分析其免疫特性。方法采用热酚水法提取铜绿假单胞菌国际抗原分型系统(International Antigen Typing System,IATS)3型菌株的脂多糖(Lipopolysacchride,LPS),去除类脂A后纯化O-SP,用1-氰基-4-二甲胺基吡啶四氟硼酸盐(CDAP)活化O-SP,己二酸二肼(ADH)作为连接臂,在碳二亚胺(EDAC)作用下,与TT结合制备O-SP-TT结合疫苗,检测其理化性质,并分析结合疫苗的免疫原性和免疫保护性。结果 O-SP收获量相当于水解LPS量的30%,其蛋白质和核酸含量均低于1.0%,O-SP衍化度为3.83%,O-SP与TT的结合率约为40%,多糖蛋白质比(w/w)为1∶2.18。O-SP-TT结合疫苗可刺激小鼠产生高效价的IgG抗体,与O-SP组相比,差异有统计学意义(P<0.05);结合疫苗免疫小鼠能保护5 LD50和10 LD50活菌的攻击,小鼠免疫O-SP-TT后兔抗血清对3 LD50和5 LD50活菌攻击具有良好的保护作用。结论制备的铜绿假单胞菌3型O-SP-TT结合疫苗具有良好的免疫原性和免疫保护性,该疫苗有望成为防治IATS 3型铜绿假单胞菌感染的有效疫苗。 Objective To prepare Pseudomonas aeruginosa-IATS(International Antigen Typing System)3 O-specific polysaccharide-tetanus toxoid conjugate vaccine and analyze its immune characteristics.Methods Lipopolysaccharide(LPS)was isolated from P.aeruginosa IATS 3 by hot phenol method,in which the lipid A was removed.The obtained O-specific polysaccharide(O-SP)was purified and ac-tivated with CDAP,then conjugated to tetanus toxoid(TT)in mediation of EDAC using adipic acid dihydrazide(ADH)as a linker.The prepared conjugate vaccine was analyzed for physic-chemical property,immunogenicity and immune protection.Results The yield of O-SP was equivalent to 30% of hydrolyzed LPS.Both the protein and nucleic acid contents in the obtained O-SP was less than 1.0%.The derivation of O-SP was 3.83%,while the binding rate to TT was about 40%,and the ratio(w / w)of polysaccharide to protein was 1 ∶ 2.18.O-SP-TT vaccine induced high titer IgG in mice,which was significantly higher than that induced with O-SP(P 0.05).The conjugate vaccine protected mice against the challenge with live bacteria at dosages of 5 and 10 LD50.Conclusion The prepared O-SP-TT conjugate showed high immunogenicity and immune protection,which might be used as an effective vaccine for prevention and treatment of infection with P.aeruginosa IATS 3.
出处 《中国生物制品学杂志》 CAS CSCD 2012年第12期1565-1568,共4页 Chinese Journal of Biologicals
关键词 铜绿假单胞菌 O-特异性多糖 破伤风类毒素 结合疫苗 免疫原性 免疫保护性 Pseudomonas aeruginosa O-specific polysaccharide(O-SP) Tetanus toxoid(TT) Conjugate vaccine Immunogenicity Immune protection
  • 相关文献

参考文献8

  • 1Rodrfguez-Rojas A,Oliver A, B16zquez J. Intrinsic and environ- mental mutagensis drive diversification and persistence of Pseu- domonas aeruginosa in chronic lung infections [J]. J Infect Dis, 2012, 205 (1): 121-127.
  • 2Vogt SL, Green C, Steven KM, et ol. The stringent response is es-sential for Pseudomonas aeruginosa virulence in the rat lung agar bead and Drosophila melanogaster feeding models of infec- tion [J]. Infect Immun, 2011, 79 (10): 4094-4104.
  • 3Dtiring G,Pier GB. Vaccines and immunotherapy against Pseu- domonas aeruginosa [J]. Vaccine, 2008, 26 (8): 1011-1024.
  • 4肖永红,沈萍,魏泽庆,陈云波,孔海深,杨青,张伟丽,陈晓,李兰娟.Mohnarin 2010年度全国细菌耐药监测[J].中华医院感染学杂志,2011,21(23):4896-4902. 被引量:132
  • 5李耘,吕媛,王珊.2010年度卫生部全国细菌耐药监测报告:非发酵革兰阴性杆菌耐药监测[J].中华医院感染学杂志,2011,21(24):5133-5137. 被引量:65
  • 6Jyot J, Balloy V,Jouvion G, et al. Type II secretion system of Pseudomonas oeruginosa : in vivo evidence of a significant role in death due to lung infection [J]. J Infect Dis, 2011, 203(10): 1369-1377.
  • 7Warren AE, Boulianne-Larsen CM, Chandler CB,et al. Genotyp- ic and phenotypic variation in Pseudomonas aeruginosa reveals signatures of secondary infection and mutator activity in certain cystic fibrosis patients with chronic lung infections [J]. Infect Im- mun, 2011,79 ( 12): 4802-4818.
  • 8Kossaczka Z, Shiloach J, Johnson V,et ol. Vibrio cholerae 0139 conjugate vaccines: synthesis and immunogenicity of V. cholerae O139 capsular polysaccharide conjugates with recombinant diph- theria toxin mutant in mice [J]. Infect Immun, 2000,68 (9): 5037- 5043.

二级参考文献14

  • 1XIONG Zi-zhong ZHU De-mei WANG Fu ZHANG Ying-yuan.CTX-M-14, CTX-M-24 and resistance in Escherichia coli and Klebsiella pneumoniae clinical isolates[J].Chinese Medical Journal,2006(2):160-164. 被引量:13
  • 2McGowan JE.Resistance in nonfermenting gram-negativebacteria:multidrug resistance to the maximum[J].Associa-tion for Professionals in Infection Control and Epidemiology,2006,34(suppl.1):S29-S37.
  • 3Clinical and Laboratory Standards Institute.Performancestandards for antimicrobial susceptibility testing;nineteenthinformational supplement[S].Wayne:Clinical and Labora-tory Standards Institute,2010.
  • 4Farrell DJ,Turnidge JD,Bell J,et al.The in vitro evaluationof tigecycline tested against pathogens isolated in eight coun-tries in the Asia-Western Pacific region(2008)[J].J Infect,2010,60(6):440-451.
  • 5Koomanachai P,Bulik CC,Kuti JL,et al.Pharmacodynamicmodeling of intravenous antibiotics against gram-negativebacteria collected in the United States[J].Clinical Therapeu-tics,2010,32(4):766-779.
  • 6Mendes RE,Farrell DJ,Sader HS,et al.Comprehensive as-sessment of tigecycline activity tested against a world widecollection of Acinetobacter spp.(2005-2009)[J].Diag Mi-crobio Infect Dis,2010,68(3):307-311.
  • 7Wang YF and Dowzicky MJ.In vitro activity of tigecyclineand comparators on Acinetobacter spp.isolates collectedfrom patients with bacteremia and MIC change during theTigecycline Evaluation and Surveillance Trial,2004to 2008[J].Diag Microbio Infect Dis,2010,68(1):73-79.
  • 8Vlieghe E,Phoba MF,Tamfun JJM,et al.Antiviotic resist-ance among bacterial pathogens in Central Africa:a review ofthe published literature between 1955and 2008[J].Int J An-timicrob Agent,2009,34(4):295-303.
  • 9赵彩芸,肖永红,王珊,李耘,刘健,杨维维,郝凤兰.临床分离耐甲氧西林金黄色葡萄球菌染色体mec盒基因的分型[J].中华传染病杂志,2007,25(10):611-616. 被引量:23
  • 10肖永红.开展细菌耐药监测 促进抗菌药物合理应用[J].中国执业药师,2009,6(3):3-5. 被引量:10

共引文献192

同被引文献18

  • 1马庆华,傅元欣,冯潇,魏然,高雪军,朱莉萍.疫苗中残余CDAP检测方法的建立[J].微生物学免疫学进展,2011,39(4):34-39. 被引量:2
  • 2林茂虎,鲁鸿,贾宁.变形菌属引发导尿管相关尿路感染的研究[J].中华医院感染学杂志,2004,14(4):468-470. 被引量:25
  • 3赵志强,杨朝晖,计永莉,杜琳,谢贵林.甲型副伤寒结合疫苗的制备及其免疫原性研究[J].中华微生物学和免疫学杂志,2006,26(11):1048-1052. 被引量:9
  • 4Kossaczka Z, Shiloaeh J, Ohnson V, et al. Vibrio cholerae O139 conjugate vaccines: synthesis and immunogenicity of V. cholerae O139 capsular polysaccharide conjugates with recombinant diph- theria toxin mutant in mice[J]. Infect lmmun, 2000, 68 ( 9 ) : 5037 -5043.
  • 5Tam VH, Chang KT, Abdelraouf K, et al. Prevalence, resistance mechanisms, and susceptibility of muhidrug-resistant bloodstream isolates of Pseudonwnas aeruginosa[J]. Antimicrob Agents Che- mother, 2010, 54(3) :1160-1164.
  • 6Kamei A, Wu WH, Traficante DC, et al. Collaboration between maerophages and vaccine-induced CD4+ T cells confers protection against lethal Pseudomonas aeruginosa pneumonia during neutrope- nia[J]. J Infect Dis, 2013, 207(1) :39-49.
  • 7Akhabue E, Synnestvedt M, Weiner MG, et al. Cefepime-resist- ant Pseudomonas aeruginosa [ J ]. EID J, 2011,17 ( 6 ) : 1037- 1043.
  • 8Doring G,Pier GB. Vaccines and immunotherapy against Pseudo- monas aeruginosa [ J ]. Vaccine, 2008, 26 ( 8 ) : 1011 - 1024.
  • 9de Bentzmann S, Pl~siat P. The Pseudomonas aer~ginosa oppor- tunistic pathogen and human infections [J]. Environ Microbiol, 2011,13 (7) :1655-1665.
  • 10Hota S, Hirji Z, Stockton K, et al. Outbreak of multidrug-resist- ant Pseudomonas aeruginosa colonization and infection secondary to imperfect intensive care unit room design [ J]. Infect Control Hosp Epidemiol, 2009, 30( 1 ) :25-29.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部